Angela Richardson

Dr. Angela Richardson

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in World Neurosurgery
Verified
Journal Article
Closed access
NSNicole Silva
Nicole Silva
SCSamantha Cerasiello
Samantha Cerasiello
ASAlexa Semonche
Alexa Semonche
ASAlaba Sotayo
Alaba Sotayo
JLJustin Luis
Justin Luis
JEJean Anderson Eloy
Jean Anderson Eloy

1 June 2019 in World Neurosurgery
Verified
Journal Article
Closed access
ARAngela M. Richardson
Angela M. Richardson
DMDavid J. McCarthy
David J. McCarthy
JSJagteshwar Sandhu
Jagteshwar Sandhu
RMRoxanne Mayrand
Roxanne Mayrand
CGChristina Guerrero
Christina Guerrero
Michael E. IvanMichael E. Ivan
Michael E. Ivan

9 November 2021 in Cureus
Verified
Journal Article
Open access
HBHailey C. Budnick
Hailey C. Budnick
ARAngela Richardson
Angela Richardson
KSKevin Shiue
Kevin Shiue
GWGordon Watson
Gordon Watson
SNSook K. Ng
Sook K. Ng
MSMitesh V. Shah
Mitesh V. Shah
GammaTile® (GT Medical Technologies, Tempe, Arizona) is a surgically targeted radiation source, approved by FDA for brachytherapy in primary and secondary brain neoplasms. Each GammaTile is composed of a collagen sponge with four seeds of cesium 131 and is particularly useful in recurrent tumors. We report our early experience in seven patients with recurrent gliomas to assess this type of brachytherapy with particular attention to ease of use, complication, and surgical planning. This study represents a retrospective chart review of surgical use and early clinical outcomes of GammaTile in recurrent gliomas. The number of tiles was planned using pre-operative imaging and dosimetry was planned based on post-operative imaging. Patients were followed during their hospital stay and were followed up after discharge. Parameters such as case length, resection extent, complication, ICU length of stay (LOS), hospital LOS, pre-operative Glasgow Coma Scale (GCS), immediate post-operative GCS, post-operative imaging findings, recurrence at follow-up, length of follow-up, and dosimetry were collected in a retrospective manner. Seven patients were identified that met the inclusion criteria. Two patients were diagnosed with recurrent glioblastoma multiforme (GBM), one lower-grade glioma that recurred as a GBM, one GBM that recurred as a gliosarcoma, and two recurrent oligodendrogliomas. We found that operation time, ICU LOS, hospital LOS, pre- and post-operative GCS, and post-operative complications were within the expected ranges for tumor resection patients. Further, dosimetry data suggests that six out of seven patients received adequate radiation coverage, with the seventh having implantation limitations due to nearby organs at risk. We report no postoperative complications that can be attributed to the GammaTiles themselves. In our cohort, we report seven cases where GammaTiles were implanted in recurrent gliomas. No implant-related post-operative complications were identified. This early data suggests that GammaTile can be a safe form of brachytherapy in recurrent gliomas.

1 March 2019 in World Neurosurgery
Verified
Journal Article
Closed access
ARAngela M. Richardson
Angela M. Richardson
VAValerie L. Armstrong
Valerie L. Armstrong
JGJoanna E. Gernsback
Joanna E. Gernsback
SGSakir H. Gultekin
Sakir H. Gultekin
RKRicardo J. Komotar
Ricardo J. Komotar

1 July 2023 in Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
RHRosemary T. Behmer Hansen
Rosemary T. Behmer Hansen
RHRyan A. Behmer Hansen
Ryan A. Behmer Hansen
JGJustin L. Gold
Justin L. Gold
SBSai Batchu
Sai Batchu
RLRebecca D. Lozada
Rebecca D. Lozada
ARAngela Richardson
Angela Richardson
OBJECTIVE: This study was performed to compare authorship trends, by gender, in the neurosurgical oncology literature. METHODS: Complete author listings for neurosurgical oncology articles published between 1944 and 2021 in five top neuro-oncology journals were extracted from the PubMed database and journal websites on December 2, 2021. Author gender was characterized with the web application programming interface (API) genderize.io. The statistical significance (p < 0.05) of time-, journal-, and gender-based differences was determined by independent-samples t-test, chi-square test, and/or Fisher’s exact test. RESULTS: A total of 14,020 articles were written by 67,115 unique authors occupying 97,418 authorship spots. The gender for 80,030 authorship positions (82.2%) was successfully characterized. Male authors were significantly more likely than the female authors to have a first-author publication, have a last-author publication, and have authored multiple articles within the data set. Among authors who published in multiple different years (n = 11,532), women had a shorter time window of publishing (5.46 vs 6.75 years between first and last publication: mean difference [MD] 1.28 [95% CI 1.06–1.50] years, p < 0.001). During this window, however, they were slightly more productive than the men, based on the mean number of publications per year (1.06 vs 1.01 articles: MD 0.05 [95% CI 0.02–0.09] articles, p = 0.002). The percentage of female authors on each neuro-oncology research team has increased by 3.3% (95% CI 2.6%–3.9%) per decade to a mean of 26.5% in the 2020s. Having a female last author was positively associated with having a female first author (OR 2.57 [95% CI 2.29–2.89]) and a higher proportion of women on the research team overall. The percentages of female first and last authors increased at significantly higher rates in medically oriented journals than in surgically oriented journals (first authors: 0.72% [95% CI 0.58%–0.87%] vs 0.36% [95% CI 0.30%–0.42%] per year, p < 0.001; and last authors: 0.50% [95% CI 0.38%–0.62%] vs −0.03% [95% CI −0.10% to 0.05%] per year, p < 0.001). CONCLUSIONS: Female authorship in top neuro-oncology journals has increased since the 1940s, with female-led teams showing greater gender diversity. However, female researchers lag behind their male counterparts in quantity of published research and are less likely to hold first or last authorship positions. This difference is more pronounced in the three neurosurgical oncology journals than in the two medical neuro-oncology journals, which may reflect the relatively low female representation in neurosurgery relative to medical oncology. Collectively, these trends have meaningful implications for career advancement, which is often dependent on academic productivity.

15 November 2022 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
PDF file
RHRyan Behmer Hansen
Ryan Behmer Hansen
JGJustin L. Gold
Justin L. Gold
WIWilliam A. Blocher Iii
William A. Blocher Iii
SPSamantha D. Palma
Samantha D. Palma
SSStephen J. Susman
Stephen J. Susman
ARAngela Richardson
Angela Richardson
Objective The North American Skull Base Society (NASBS) annual conference brings together skull base researchers from surgical and nonsurgical fields. Our objective was to quantify the contributions of the authors by gender, who presented their work at NASBS and were subsequently published in the Journal of Neurological Surgery Part B: Skull Base. Methods Oral and poster abstracts presented at the NASBS annual meeting from January 1, 2011 to December 31, 2020 were extracted from the Journal of Neurological Surgery Part B: Skull Base. The genderize.io Web application programming interface was utilized to determine authorship gender. A minority of first and last authors had departmental affiliations listed; a subgroup analysis was performed of these authors. Results Female gender was assigned to 498 (17.8%) of the 2,798 first authors and 269 (9.7%) of the 2,762 last authors. Female authorship has consistently increased over the last decade. Representation was higher in otolaryngology (23.3% of first authors, 12.1% of last authors; p = 0.018) than neurosurgery (13.5% of first authors, 4.3% of last authors; p = 0.004). Female researchers were not less likely than their male counterparts to receive prestigious oral presentations. Of the 52 total countries represented, 20 (38.5%) had at least one female first author. Representation varied dramatically between countries. Conclusion The NASBS' efforts have undoubtedly contributed to these impressive strides toward gender parity. More work is needed to ensure that the best and the brightest, regardless of background, continue to contribute to skull base surgery research.